Carol C. Pilbeam, M.D., Ph.D.
Professor of Medicine and OrthopaedicsDirector, M.D./Ph.D. Combined Degree Program
|
Academic Office Location: Medical Arts Research Building University of Connecticut Health Center 263 Farmington Avenue Farmington, CT 06030-5456 |
|
| Phone: | 860-679-3846 |
| Fax: | 860-679-1932 |
| Website(s): |
Cell Biology Graduate Program Skeletal, Craniofacial & Oral Biology Graduate Program Biomedical Engineering Program |
Education
Post-Graduate Training
Awards
| Degree | Institution | Major |
|---|---|---|
| M.D. | Yale University School of Medicine | Medicine |
| Ph.D. | Yale University | Geophysics |
| B.S. | SMU | Geology |
Post-Graduate Training
| Training | Institution | Specialty |
|---|---|---|
| Fellowship | NSF | Geology/Geophysics Graduate Program at Yale |
| Internship | Waterbury Hospital | Intern in Medicine |
| Residency | Waterbury Hospital | Internal Medicine |
| Fellowship | HARVARD MEDICAL SCHOOL | Geriatrics |
| Fellowship | Brookdale Foundation | Brookdale National Fellowship in Geriatrics at UCHC |
Awards
| Name of Award/Honor | Awarding Organization |
|---|---|
| Bridging award (national competition, 1 of 2 selected) | American Society of Bone and Mineral Research |
| JBMR paper (Chikatzu et al, 2002) selected as 20th Anniversary Classic | JBMR |
| Paper chosen as one of 12 best papers published in Journal of Bone and Mineral Research over 20 year period and republished in journal as 20th Anniversary Classic | Journal of Bone and Mineral Research |
| Donaghue Foundation Investigator in Health Related Research Award (2002-7) | |
| Fred F. Schudy Memorial Research Award | AAOF |
| Honorary member, Chinese Hard Tissue Society | |
| CT Community Care Award for Research in Geriatrics | |
| Travel award XII | International Conference on Calcium Regulating Hormones |
| Shannon Award (new investigator award), 1993-1995 | NIH |
| Abstract award | Am. Geriatrics Soc. |
| Brookdale Foundation National Fellowship in Geriatrics 1987-1990 | Brookdale Foundation |
| National Science Foundation Fellowship (graduate work at Yale)1964- 1967 | National Science Foundation |
| Phi Beta Kappa |
I lead first and second year conferences on bone biology and calcium metabolism and teach skeletal biology in the SCOB program for graduate students.
1. Regulation and function of cyclooxygenase-2 (COX-2) in bone. COX-2 is responsible for most prostaglandin regulation in bone. Ongoing research projects include examination of transcriptional regulation of COX-2 in osteoblastic cells and examination of the effects of COX-2 gene disruption on bone resorption and formation. We are particularly interested in the inhibition by COX-2 of the anabolic effects of PTH on bone, an effect that appears to be mediated by cells of the osteoclast lineage.
2. Role of COX-2 in the osteoblastic response to mechanical loading. COX-2 may mediate effects of mechanical loading on bone. We are studying fluid shear stress induction of COX-2 expression--signaling pathways and transactivating factors involved.
2. Role of COX-2 in the osteoblastic response to mechanical loading. COX-2 may mediate effects of mechanical loading on bone. We are studying fluid shear stress induction of COX-2 expression--signaling pathways and transactivating factors involved.
Accepting students for Lab Rotations: Summer '13, Fall '13, Spring '14
Journal Articles
-
Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice
(2011) Bone
-
Parathyroid hormone induction of cyclooxygenase-2 in murine osteoblasts: role of the calcium-calcineurin-NFAT pathway
(2010) J Bone Miner Res 4 (25) 819-29
-
Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: A pilot study
(2010) Supportive Care in Cancer 1 (18) 95-103
-
Bone morphogenetic protein 2 enhances PGE<sub>2</sub>-stimulated osteoclast formation in murine bone marrow cultures
(2009) Prostaglandins and Other Lipid Mediators 40241 (90) 76-80
-
Effects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice
(2009) Bone 1 (45) 98-103
-
Effects of prostaglandin E<sub>2</sub> on bone in mice in vivo
(2009) Prostaglandins and Other Lipid Mediators 40180 (89) 20-25
-
Effects of Prostaglandin E2 on bone in mice in vivo.
(2009) Prostaglandins Other Lipid Mediat (89) 20-25
-
Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity
(2009) Journal of Cellular Biochemistry 3 (108) 621-630
-
Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice
(2009) Prostaglandins and Other Lipid Mediators 40180 (88) 36-41
-
Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro
(2008) Biochemical and Biophysical Research Communications 4 (372) 536-541
-
Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist
(2008) Prostaglandins and Other Lipid Mediators 4-Jan (86) 35-40
-
Effect of MKP-1 deletion on the fluid shear stress induction of COX-2 expression in osteoblasts.
(2008) J Bone Miner Res (23) S234
-
Measurement of muscle disease by quantitative second-harmonic generation imaging.
(2008) Journal of biomedical optics 4 (13) 44018
-
Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro
(2007) Bone 1 (41) 68-76
-
Effects of prostaglandin E2 and lipopolysaccharide on osteoclastogenesis in RAW 264.7 cells
(2007) Prostaglandins Leukotrienes and Essential Fatty Acids 4-Mar (77) 181-186
-
Null mutation for Macrophage Migration Inhibitory Factor (MIF) is associated with less aggressive bladder cancer in mice
(2007) BMC Cancer (7)
-
Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: Involvement of prostaglandins
(2007) Journal of Bone and Mineral Research 7 (22) 1002-1010
-
Fluid flow induces rankl expression in primary murine calvarial osteoblasts
(2006) Journal of Cellular Biochemistry 5 (98) 1271-1283
-
Mice with a null mutation for macrophage migration inhibitory factor have lower stage tumors in a model of bladder cancer.
(2006) J Am Geriatr Soc (54) 12
-
Null mutation in macrophage migration inhibitory factor (MIF) prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.
(2006) Am J Physiol Renal Physiol (291) F1343-F1353
-
Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction
(2006) American Journal of Physiology - Renal Physiology 6 (291)
-
Overexpression of Cox-2 in human osteosarcoma cells decreases proliferation and increases apoptosis
(2006) Cancer Research 13 (66) 6657-6664
-
Role of Cbfa1/Runx2 in the fluid shear stress induction of COX-2 in osteoblasts
(2006) Biochemical and Biophysical Research Communications 4 (341) 1225-1230
-
Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: Role of the EP2 receptor
(2005) Journal of Bone and Mineral Research 1 (20) 23-29
-
Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism?
(2005) Endocrinology 4 (146) 1843-1853
-
Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: Impaired responsiveness in heterozygotes
(2005) Prostaglandins and Other Lipid Mediators 4-Jan (78) 19-26
-
Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells
(2004) Journal of Cellular Biochemistry 4 (93) 741-752
-
Extracellular calcium induces COX-2 in osteoblasts via a PKA pathway
(2004) Biochemical and Biophysical Research Communications 2 (322) 395-402
-
Role of cyclooxygenase-2 in bone resorption
(2003) Journal of UOEH 2 (25) 185-195
-
Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: Role in effects of bone morphogenetic protein 2 in vitro and in vivo
(2002) Journal of Bone and Mineral Research 8 (17) 1430-1440
-
Cell-to-cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption
(2002) Endocrine Journal 4 (49) 483-495
-
Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice
(2002) Bone 4 (30) 567-573
-
Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro
(2002) Bone 1 (30) 159-163
-
Fluid flow induction of cyclo-oxygenase 2 gene expression in osteoblasts is dependent on an extracellular signal-regulated kinase signaling pathway
(2002) Journal of Bone and Mineral Research 2 (17) 266-274
-
Fluid flow induction of cyclooxygenase-2 gene expression in osteoblasts depends on the ERK signaling pathway.
(2002) J Bone Miner Res (17) 266-274
-
Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo
(2002) Prostaglandins and Other Lipid Mediators 4-Mar (67) 173-180
-
Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells
(2002) Journal of Bone and Mineral Research 3 (17) 502-512
-
Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells
(2000) Journal of Cellular Biochemistry 2 (78) 197-209
-
Involvement of C/EBP transcription factors in prostaglandin G/H synthase-2 gene induction by interleukin-1 in osteoblastic MC3T3-E1 cells.
(2000) J Bone Miner Res (15) 1146-1138
-
Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin-1 in osteoblastic MC3T3-E1 cells
(2000) Journal of Bone and Mineral Research 6 (15) 1138-1146
-
Knockout of the murine prostaglandin EP2 receptor impairs Osteoclastogenesis in vitro
(2000) Endocrinology 6 (141) 2054-2061
-
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture
(2000) Journal of Clinical Investigation 6 (105) 823-832
-
Prostaglandin G/H synthase-2 is required for maximal stimulation of osteoclast-like cell formation in murine marrow and spleen cultures.
(2000) J Clin Invest (105) 823-832
-
Low dose estrogen and calcium have an additive effect on bone resorption in older women
(1999) Journal of Clinical Endocrinology and Metabolism 1 (84) 179-183
-
Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy
(1998) Endocrinology 6 (139) 3022-3025
-
Regulation of prostaglandin G/H synthase-2 expression by interleukin-1 in human osteoblast-like cells
(1998) Journal of Bone and Mineral Research 7 (13) 1066-1075
-
Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells
(1997) Journal of Bone and Mineral Research 8 (12) 1198-1203
-
Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype
(1997) Prostaglandins 4 (54) 713-725
-
Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 3',5'-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells
(1997) Endocrinology 9 (138) 3594-3600
-
Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells
(1997) Journal of Bone and Mineral Research 1 (12) 45-51
-
Regulation of inducible prostaglandin G/H synthase by interleukin-1, transforming growth factors-alpha and -beta and prostaglandins in bone cells
(1997) Advances in Experimental Medicine and Biology B (400) 617-623
-
Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation
(1997) Endocrinology 6 (138) 2372-2379
-
Transforming growth factor-beta1 regulation of prostaglandin G/H synthase- 2 expression in osteoblastic MC3T3-E1 cells
(1997) Endocrinology 11 (138) 4672-4682
-
Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment
(1996) Journal of Cellular Physiology 2 (166) 370-379
-
Interleukin-4 inhibits prostaglandin G/H synthase-2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures
(1996) Journal of Bone and Mineral Research 3 (11) 358-366
-
Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy
(1996) Journal of Bone and Mineral Research 12 (11) 1926-1934
-
Parathyroid Hormone Induces Prostaglandin G/H Synthase-2 Expression by a Cyclic Adenosine-Monophosphate-Mediated Pathway in the Murine Osteoblastic Cell Line MC3T3-E1
(1996) Endocrinology 12 (137) 5435-5440
-
The effect of a short course of calcium and vitamin D on bone turnover in older women
(1996) Osteoporosis International 4 (6) 314-319
-
Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins
(1995) Journal of Bone and Mineral Research 3 (10) 406-414
-
Expression and regulation of prostaglandin F receptor mRNA in rodent osteoblastic cells
(1995) Prostaglandins 6-May (50) 349-358
-
Fracture incidence in postmenopausal women with primary hyperparathyroidism. ,
(1995) Surgery (118) 109-114
-
Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae
(1995) Journal of Clinical Investigation 1 (96) 539-548
-
The short term effects of tamoxifen on bone turnover in older women
(1995) Journal of Clinical Endocrinology and Metabolism 11 (80) 3287-3291
-
Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor
(1995) Journal of Clinical Investigation 2 (96) 923-930
-
Transcriptional regulation of prostaglandin G/H synthase 2 by basic fibroblast growth factor in bone.
(1995) J Clin Invest (96) 923-930
-
Anabolic effects of 3,3',5-triiodothyronine and triiodothyroacetic acid in cultured neonatal mouse parietal bones
(1994) Endocrinology 3 (135) 971-976
-
Comparison of the effects of 3,5,3'-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae
(1994) Journal of Bone and Mineral Research 2 (9) 247-253
-
Measurement of interleukin-1 stimulated constitutive prostaglandin G/H synthase (cyclooxygenase) mRNA levels in osteoblastic MC3T3-E1 cells using competitive reverse transcriptase polymerase chain reaction
(1994) Endocrine Research 3 (20) 219-233
-
Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae
(1994) Endocrinology 3 (135) 1157-1164
-
Stimulation of prostaglandin E2 production by interleukin-1 and transforming growth factor-alpha in osteoblastic MC3T3-E1 cells
(1994) Journal of Bone and Mineral Research 6 (9) 817-823
-
The anabolic effects of progesterone on fetal rat calvaria in tissue culture.
(1994) Journal of the Society for Gynecologic Investigation 4 (1) 302-309
-
The short term effects of conjugated estrogen on bone turnover in older women
(1994) Journal of Clinical Endocrinology and Metabolism 2 (79) 366-371
-
Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on bone resorption and formation in organ culture
(1993) Bone 5 (14) 717-720
-
Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells
(1993) Journal of Biological Chemistry 34 (268) 25643-25649
-
Differential regulation of the two genes for prostaglandin endoperoxide synthase in MC3T3 E1 osteoblastic cells.
(1993) J Biol Chem (268) 25643-25649
-
Production of both 92 and 72 kDa gelatinases by bone cells.
(1992) Matrix (12) 282-290
-
Effect of 1,25-dihydroxyvitamin D<sub>3</sub> on prostaglandin E<sub>2</sub> production in cultured mouse parietal bones
(1991) Journal of Bone and Mineral Research 12 (6) 1339-1344
-
Effects and regulation of prostaglandins in bone: Possible implications for the pathogenesis of osteoporosis
(1991) Journal of Bone and Mineral Metabolism 2 (9) 39-44
-
Mechanism of regulation of prostaglandin production by parathyroid hormone, interleukin 1, and cortisol in cultured mouse parietal bones.
(1991) Endocrinology (128) 2503 -2510
-
A long term study to evaluate the relative contributions of exposure to sunlight and diet on the circulating concentrations of 25 OH D in an elderly population in Boston.
(1990) Amer J Clin Nutrition (51) 1075 -1081
-
Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae
(1990) Journal of Bone and Mineral Research 11 (5) 1183-1188
-
Inhibition by 17beta-estradiol of PTH stimulated resorption and prostaglandin production in cultured neonatal mouse calvariae
(1989) Biochemical and Biophysical Research Communications 3 (163) 1319-1324
-
Deep earthquake initiation by phase transformations.
(1976) J Geophys Res (81) 985-988
-
Circulation in central Long Island Sound.
(1975) J Geophys Res (80) 414-422
-
Stress on the bottom of an estuary.
(1975) Nature (257) 575-577
-
Acoustic velocities and energy losses in granular aggregates.
(1973) J Geophys Res (78) 810-824
-
Contact thermal conductivity in lunar aggregates.
(1973) J Geophys Res (78) 5233 -5236
Book Chapters
-
Current Therapy in Orthodontics
(2009) Mechanotransduction of Orthodontic Forces 341-352
-
Principles of Bone Biology
(2008) Prostaglandins and Bone Metabolism 1235-1271
-
The Eicosanoids
(2004) Prostaglandins, Leukotrienes, and Bone Metabolism
-
Principles of Bone Biology, second edition
(2002) Prostaglandins and Leukotrienes 874-994
-
Therapeutic Roles of Selective COX-2 Inhibitors
(2001) Cyclooxygenase-2 and bone turnover 307-328
-
Oxford Textbook of Geriatric Medicine
(2000) Osteomalacia
-
Clinical Significance and Potential of Selective COX-2 Inhibitors
(1998) Cyclooxgenase-2 and bone resorption. 49-56
-
Principles of Bone Biology
(1996) Prostaglandins and Leukotrienes. 715-728
-
Oxford Textbook of Geriatric Medicine
(1992) Osteomalacia.
-
Osteoporosis 1990
(1990) Prostaglandins and bone metabolism: Possible role in osteoporosis. 253-258
-
Geriatric Medicine
(1988) Osteoporosis. 431-439
Abstracts
-
Role of osteoclasts in the COX-2 mediated inhibition of PTH-stimulated osteoblastic differentiation in vitro.
Choudhary won President’s Poster Award
(2010) J Bone Miner Res (Suppl 1) (25)
-
Effects of MKP-1 deletion on osteoblast growth and differentiation.
Available at http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=b9f49eaa-e06d-423b-9ec4-629d067dc93e.
(2009) J Bone Miner Res (Suppl 1) (24)
-
Targeted overexpression of Cox-2 in osteoblasts.
(2009) J Bone Miner Res (Suppl 1) (24 )
-
Mechanism of BMP-2 enhancement of PGE2 stimulated osteoclastogenesis.
(2008) J Bone Miner Res (23) S263
-
PTH induces COX-2 in MC3T3-E1 osteoblasts via cAMP-PKA and caclcium-calcineurin pathways.
(2008) J Bone Miner Res (23) S140
-
BMP-2 induces sustained expression of COX-2 in MC3T3-E1 osteoblasts.
(2007) J Bone Miner Res (22) S165
-
Continuous treatment with PTH is anabolic in cultured osteoblasts from COX-2 knockout mice.
(2007) J Bone Miner Res (22) S371
-
Demonstration of an anabolic effect of prostaglandin E 2 on bone in CD-1 mice.
(2007) J Bone Miner Res (22) S167
-
Role of prostaglandins in strontium ranelate effects on osteoblastic differentiation and growth factor production.
(2007) J Bone Miner Res (22) S445
-
Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to a selective EP2 agonist.
(2006) J Bone Miner Res (21(S1)) S253
-
Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.
(2006) J Urol (175) 204
-
Regulation of MAPK phosphatase-1 by fluid flow in MC3T3-E1 osteoblastic cells.
(2006) J Bone Miner Res (21(S1)) S372
-
Role of n-3 fatty acids in osteoclastogenesis.
(2006) J Bone Miner Res (21(S1)) S393
-
Strontium ranelate effects on osteoblastic differentiation: involvement of prostaglandins.
(2006) J Bone Miner Res (21(S1)) S301
-
Macrophage migration inhibitory factor mediates smooth muscle death in bladder outlet obstruction.
(2005) J Urol (173) 38
-
Fluid flow regulation of the 3’- untranslated region of cyclooxygnase-2 in MC3T3-E1 cells.
(2005) J Bone Miner Res (20(S1)) S169
-
Null mutation in macrophage migration inhibitory factor (MIF) inhibits compensatory smooth muscle growth in bladder outlet obstruction.
(2005) J Am Geriatr Soc. (53) 8
-
Fluid shear stress induces MMP-13 in murine osteoblastic cells.
(2004) J Miner Res (19(S1)) S137
-
Effect of exogenous and endogenous prostaglandin E2 on osteoclastogenesis in the RAW 264.7 macrophage cell line.
(2004) J Bone Miner Res (19(S1)) S409
-
Effects of global or targeted deletion of the EP4 receptor on the response of cultured osteoblasts to prostaglandin E2.
(2004) J Bone Miner Res (19(S1)) S5
-
Endogenous COX-2 gene expression does not alter apoptosis in murine osteoblastic cells.
(2004) J Bone Miner Res (19(S1)) S140
-
Five minutes of fluid shear stress is sufficient to induce cyclooxygenase-2 in MC3T3-E1 cells.
(2004) J Miner Res S137 (19(S1))
-
Fluid shear stress induces cyclooxygenase-2 via activation of protein kinase D in murine primary osteoblasts.
(2004) J Miner Res (19(S1)) S390
-
Fluid shear stress induces RANKL expression in primary osteoblastic cells.
(2004) J Miner Res (19(S1)) S391
-
Overexpression of COX-2 in Saos- 2 human osteosarcoma cells increases apoptosis via oxidative stress.
(2004) J Bone Miner Res (19(S1)) S140
-
Parathyroid hormone injection induces cyclooxygenase-2 in bone, kidney, and muscle in vivo.
(2004) J Miner Res (19(S1)) S335
-
Transcription factors involved in the regulation of IL-6 in mouse calvarial osteoblasts by vasoactive intestinal peptide.
(2004) J Bone Miner Res (19(S1)) S265
-
Early induction of cyclooxygenase-2 in osteoblasts by fluid flow depends on the protein kinase C signaling pathway.
(2003) J Bone Miner Res ( 18(S2)) S218
-
Overexpression of cyclooxygenase-2 decreases proliferation of osteoblastic cells.
(2003) J Bone Miner Res (18(S2)) S340
-
Platelet-derived growth factor stimulates osteoblastic migration and proliferation via independent signaling pathways.
(2003) J Bone Miner Res (18(S2)) S194
-
Prostaglandin E2 stimulation of osteoclast formation in hematopoietic cell cultures is mediated by a soluble T cell factor.
(2003) J Bone Miner Res (18(S2)) S236
-
Biphasis effect of prostaglandin E2 on osteoclast formation from spleen cells.
(2002) J Bone Miner Res (17(S1)) S345
-
Effects of cyclooxygenase-2 gene disruption on osteoblastic cell growth.
(2002) J Bone Miner Res (17(S1)) S340
-
Effects of Prostaglandin E2 (PGE2) and selective prostaglandin E receptor (EP) agonists on 3’5’ cyclic adenosine monophosphate (cAMP) production in osteoblastic cells from wild type and EP2 or EP4 knockout mice.
(2002) J Bone Miner Res (17(S1)) S441
-
Extracellular calcium transriptionally induces cyclooxygenase-2 in osteoblasts via an ERK signaling pathway.
(2001) J Bone Miner Res (16(S1)) S427
-
Signaling pathways for the fluid shear stress induction of cyclooxygenase-2 in murine osteoblasts.
(2001) J Bone Miner Res (16(S1)) S255
-
Effects of aging on the regulation of osteoclast formation in murine bone marrow cultures.
(2000) J Bone Miner Res (15(S1)) S237
-
Fluid shear stress transcriptionally induces cyclooxygenase-2 expression in murine osteoblasts.
(2000) J Bone Miner Res (15(S1)) S499
-
IL-1 regulation of osteoblastic differentiation in murine bone marrow and primary osteoblastic cultures.
(2000) J Bone Miner Res (15(S1)) S508
-
Involvement of AP-1 and CRE sites in the parathyroid hormone induction of COX-2 promoter activity in osteoblastic MC3T3-E1 cells.
(2000) J Bone Miner Res (15(S1)) S497
-
Effects of a selective EP4 antagonist on osteoclast formation and bone resorption in vitro.
(1999) J Bone Miner Res (14(S1)) S245
-
Effects of prostaglandin G/H synthase-2 knockout on bone.
(1999) J Bone Miner Res (14(S1)) S172
-
Osteoblasts from interleukin 1 receptor type 1 knockout mice have a markedly reduced capacity to support osteoclast function.
(1999) J Bone Miner Res (14(S1)) S164
-
Prostaglandins induce ICER expression in osteoblastic cells and mouse calvariae.
(1999) J Bone Miner Res (14(S1)) S350
-
Transcriptional regulation of prostaglandin G/H synthase-2 in transgenic mice.
(1999) J Bone Miner Res S472 (14(S1))
-
AP-1 and CRE sites jointly mediate the induction of prostaglandin G/H synthase-2 promoter activity basic fibroblast growth factor in osteoblastic MC3T3-E1 cells.
(1998) J Bone Miner Res (13(S1)) S245
-
Decreased osteoclastogenic responses in marrow cultures from mice with disruption of the PGHS-2 gene.
(1998) J Bone Miner Res (13(S1)) S330
-
Expression and regulation of fibroblast growth factor-2 by cytokines and growth factors in human osteoblasts.
(1998) J Bone Miner Res (13(S1)) S440
-
Identification of promoter sites mediating induction of transcription of PGHS-2 by phobol ester in MC3T3-E1 cells.
(1998) Bone (22) 16S
-
Turnor necrosis factor-? stimulation of prostaglandin G/H synthase-2 promoter activity in osteoblastic MC3T3-E1 cells requires and intact AP-1 site.
(1998) J Bone Miner Res (13(S1)) S354
-
Basic fibroblast growth factor stimulates bone resorption through mitogenic effects on immature osteoblastic cells as well as cyclooxygenase-2 induction.
(1997) J Bone Min Res (12(S1)) S209
-
Downregulation of mRNA expression for the "decoy" interleukin-1 receptor 2 by ovariectomy in mice.
(1997) J Bone Min Res (12(S1)) S433
-
Expression and regulation of prostaglandin F receptor mRNA in rodent osteoblastic cells.
(1997) J Bone Min Res (12 (S1)) S189
-
Induction of the prostaglandin G/H synthase-2 gene by Interleukin-1 in MC3T3-E1 cells is mediated by C/EBP transcription factors.
(1997) J Bone Min Res (12(S1)) S433
-
Overexpression and suppression of prostaglandin EP2 and FP receptors in rat osteoblastic cells.
(1997) J Bone Min Res (12(S1)) 190
-
The expression and regulation of IL-1? mRNA in human osteosarcoma MG-63 cells.
(1997) J Bone Min Res (12(S1)) S433
-
Estrogen and calcium have an additive effect on bone turnover in older women.
(1996) J Bone Min Res S450 (1(S1))
-
Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype.
(1996) J Bone Min Res (11(S1)) S174
-
The effect of estrogen on serum cross-linked N-telopeptides of type I collagen.
(1996) J Bone Min Res (11(S1)) S449
-
Transcriptional induction of prostaglandin G/H synthase-2 by transforming growth factor-beta1 in osteoblastic MC3T3-E1 cells requires an intact C/EBP (N-IL6) site.
(1996) J Bone Min Res (11(S1)) S378
-
Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells.
(1995) J Bone Min Res (10(S1)) S418
-
Identification of prostaglandin receptor mRNA in bone cells by reverse transcriptase polymerase chain reaction methodology.
(1995) J Bone Min Res (10(S1)) S420
-
Increased production of inflammatory mediators immed-iately after surgery by marrow stromal cell cultures from sham operated and ovariectomized mice.
(1995) J Bone Min Res (10(S1)) S346
-
Low dose conjugated estrogen reduces biochemical markers of bone turnover in older women.
(1995) J Bone Min Res (10(S1)) S256
-
Parathyroid hormone induces prostaglandin synthase-2 gene expression in MC3T3-E1 cells.
(1995) J Bone Min Res (10(S1)) S280
-
Pulsating fluid flow stimulates prostaglandin E2 release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells.
(1995) J Bone Min Res (10(S1)) 1S405
-
Retinoic acid inhibits induction of prostaglandin G/H synthase-2 mRNA and promoter activity in MC3T3 E 1 osteoblastic cells.
(1995) J Bone Min Res (10(S1)) S496
-
Transcriptional regulation prostaglandin G/H synthase 2 by transforming growth factor ß in MC3T3 E1 cells.
(1995) Bone (16(S1)) 39
-
Nuclear factor binding to an NF-IL-6 site in the prostaglandin G/H synthase 2 promoter induced by IL 1 in MC3T3 E1 cells.
(1994) J Bone Min Res (9(S1)) S122
-
Ovariectomy enhances and estrogen replacement inhibits the activity of marrow factors which stimulate prostaglandin production in cultured mouse calvariae.
(1994) J Bone Min Res (9(S1)) S263
-
Ovariectomy or estrogen treatment do not alter interleukin 6 mRNA expression in adult murine bone and bone marrow.
(1994) J Bone Min Res (9(S1)) S389
-
Regulation of inducible prostaglandin G/H synthase mRNA levels and promoter activity by basic fibroblast growth factor in osteoblastic cells.
(1994) J Bone Min Res (9(S1)) S124
-
Regulation of prostaglandin production and bone resorption by interleukin 4 (IL 4) in cultured mouse calvariae.
(1994) J Bone Min Res (9(S1)) S236
-
The effect of calcium and vitamin D supplementation on bone turnover in healthy older women.
(1994) J Bone Min Res (9(S1)) S391
-
Transcriptional regulation of inducible prostaglandin G/H synthase (PGHS 2) in osteoblastic cells.
(1994) J Bone Min Res (9(S1)) S357
-
Auto amplification of inducible prostaglandin G/H synthase (cyclooxygenase)in osteoblastic MC3T3 E1 and Pyla cells.
(1993) J Bone Miner Res (8(S1)) S161
-
Effects of a short course of conjugated estrogen on bone turnover in older women
(1993) J Bone Miner Res ( 8(S1):) S253
-
Insulin like growth factor binding protein 5 accumulates in bone matrix and is released by parathyroid hormone and prostaglandin E2.
(1993) J Bone Miner Res (8(S1)) S237
-
Quantitation of constitutive prostaglandin G/H synthase (cyclooxygenase) mRNA levels in mouse osteo-blastic MC3T3 E1 cells using competitive polymerase chain reaction.
(1993) J Bone and Miner Res S299 (8(S1))
-
Regulation of inducible prostaglandin G/H synthase (cyclooxygenase) by interleukin 1 and transform¬ing growth factors ? and ß in osteoblastic cells.
(1993) J Bone Miner Res (8(S1)) S299
-
Role of inducible prostaglandin G/H synthase (cyclooxygenase) in the regulation of prostaglandin produc¬tion in cultured mouse calvariae.
(1993) J Bone Miner Res (8(S1)) S159
-
Separate regulation of the mRNA transcripts for the two prostaglandin endoperoxide synthases in MC3T3 E1 osteoblastic cells by serum and glucocorticoid.
(1993) Calcif Tissue Int (52(S1)) S99
-
Short term effects of tamoxifen on bone turnover in older postmenopausal women.
(1993) J Bone Miner Res ( 8(S):) S252
-
Comparison of the effects of 3,5,3' triiodothyro¬acetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones.
(1992) J Bone Miner Res (7(S1)) S145
-
Short term effects of estrogen on bone turnover in older women.
(1992) Bone and Mineral (17(S1)) 357
-
Estradiol inhibition of 1,25 dihydroxyvitamin D3 stimulated release in cultured fetal rat long bones.
(1991) J Bone Miner Res (6(S1)) S99
-
Inhibition of prostaglandin E2 production by 17ß estradiol in osteoblast like cells.
(1991) Calcif Tissue Int (48(S1)) A31
-
Comparison of the effects of various forms of synthetic human parathyroid hormone related peptide of malignancy on bone resorption and formation in organ culture.
(1990) J Bone Miner Res (5(S2)) S475
-
In vitro inhibition of interleukin 1 stimulated prostaglandin E2 production by 17ß estradiol.
(1990) Calcif Tissue Int (46(S2)) A44
-
Stimulation of prostaglandin E2 production in an immortalized osteoblastic cell line (Py1a) by arachidonic acid, transforming growth factor 6, and interleukin 1.
(1990) J Bone Miner Res (5(S2)) S310
-
Effects of testosterone on IL 1 and PTH stimulated prostaglandin production and resorption in neonatal mouse calvariae.
(1989) J Bone Miner Res (4(S1):) S283
-
In vitro inhibition of PTH stimulated prostaglandin (PGE2) production by 17 beta estradiol (ßE2).
(1988) J Bone Miner Res (3(S1)) S219
-
Vitamin D status in nursing home elders.
(1988) The Gerontologist (28) 23A
Conference Papers
-
Gene deletion of mPGES-1 results in a significant reduction in tumor stage and burden in the BBN mouse model of bladder cancer. Highly Rated Abstract, Top 2%
(2010) (51) 596-597
-
Oral inhibitors of Macrophage Migration Inhibitory Factor significantly reduce tumor burden in a mouse model of bladder cancer.
(2010) (51) 373
-
BMP-2 enhances PGE2-stimulated osteoclastogeneis.
(2006)
-
Cyclooxygenase-2 knockout does not prevent bone loss after ovariectomy.
(2006) J Bone Miner Res (21(S1)) S413
-
Mice with a null mutation for macrophage migration inhibitory factor have lower stage tumors in a model of bladder cancer.
Taylor won New Investigator Award.
(2006)
-
Effects of genetic background on phenotype of cyclooxygenase-2 knockout mice.
(2005) J Bone Miner Res (20(S1)) S182
-
Locomotion in vitamin D receptor gene knockout mice.
(2005)
-
Macrophage migration inhibitory factor (MIF) inhibits compensatory smooth muscle growth in bladder outlet obstruction.
(2005)
-
Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E 2 and selective prostaglandin receptor agonists in murine osteoblastic cells
(2004) Bone 5 (34) 827-834
-
Extracellular Calcium Is a Potent Inducer of Cyclo-oxygenase-2 in Murine Osteoblasts Through an ERK Signaling Pathway
(2003) Journal of Bone and Mineral Research 10 (18) 1813-1824
-
The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines
(2003) Bone 5 (33) 798-804
-
Fluid flow induces COX-2 expression in MC3T3-E1 osteoblasts via a PKA signaling pathway
(2002) Biochemical and Biophysical Research Communications 1 (297) 46-51
-
Transforming growth factor-beta1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3-E1 cells.
(1997)
-
The role of prostaglandins in the regulation of bone metabolism
(1995) Clinical Orthopaedics and Related Research 313 36-46
-
Prostaglandins: Mechanisms of action and regulation of production in bone
(1993) Osteoporosis International SUPPL. 1 (3) 136-140
Editorials
-
Hip fractures and vitamin D. Guest editorial
(1991) Complications in Orthopedics
Erratums
Notes
-
Commentary: Take two aspirin for osteoporosis? Does aspirin have potential as an anti-osteoporosis drug? A new study by Yamaza and colleagues, published in PLoS One suggests that it just might.
(2008) IBMS BoneKEy Newsletter (Dec. 15)
Reviews
-
Lawrence G. Raisz november 13, 1925-august 25, 2010 In memoriam.
(2011) J Bone Miner Res (26) 903-11
-
Prostaglandins in bone: Bad cop, good cop?
(2010) Trends in Endocrinology and Metabolism 5 (21) 294-301
-
Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies
(2008) Expert Review of Anticancer Therapy 7 (8) 1125-1134
-
Treatment of osteoporosis
(1995) Annual Review of Medicine (46) 249-256
-
Effects and regulation of prostaglandins in bone: Possible implications for the pathogenesis of osteoporosis. ,.
(1992) J Bone Miner Metab (Japan), 39 (9) 44
-
Mechanical properties of granular media.
(1975) Annual Review of Earth (3) 343-360
| Title or Abstract | Sponsor/Event | Date/Year | Location |
|---|---|---|---|
| Anabolic effects of intermittent PTH are impaired in MAP kinase phosphatase-1 knockout mice. Xu M, Ma L, Choudhary S, Vosnesensky O, Adams G, Raisz L, Pilbeam C. | American Society of Bone and Mineral Research | 2010 | Toronto, Canada |
| Intermittent PTH has increased anabolic effects in cyclooxygenase-2 knockout mice. Xu won travel award. Xu M, Gao Q, Voznesensky O, Choudhary S, Diaz-Doran V, Raisz L, and Pilbeam C. | American Society of Bone and Mineral Research | 2007 | Honolulu, Hawaii |
| COX-2 and PTH | Musculoskeletal Institute Research Day | 2006 | |
| Discussant; presentation of my research | Orthopedics Resident’s Graduation | 2006 | |
| Effects of global or targeted deletion of the EP4 receptor on the response of cultured osteoblasts to prostaglandin E2. Raisz LG, Alander CA, Zhan P, Breyer MD, Kream BE, and Pibeam CC. | American Society of Bone and Mineral Research | 2004 | |
| COX-2 and osteosarcoma | Research Retreats or Research Days: UCONN Comprehensive Cancer Center Retreat | 2004 | UCONN |
| update on research | Center on Aging Retreat | 2004 | |
| BMP-2 induces COX-2 in osteoblasts via a Cbfa1 binding site: Role in osteoblast and osteoclast differentiation and ectopic bone formation. | Bones and Teeth Gordon Conference | 2001 | Kimball Academy, NH. |
| Prostaglandins and Bone. | Geriatrics Division, University of Wisconsin | 2000 | Madison, WI |
| topics included mechanical loading of bone, role of COX-2 in bone | Geriatrics grand rounds | 2000 | UCHC |
| Function of COX-2 in bone. The Potential of Specific Cox-2 Inhibition | William Harvey Research Conference | 1999 | Lisbon, Portugal |
| Role of COX-2 in bone turnover. | Merck management meeting | 1999 | Skamandia Lodge, Steveson, WA |
| Bone metabolism in prostaglandin G/H synthase deficient mice. | Bones and Teeth Gordon Conference | 1999 | Kimball Academy, NH |
| Osteoclast function is inhibited in marrow cultures from COX-2 knockout mice. Okada Y, Freeman A, Tomita M, Morham S, and Pilbeam C. | Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases | 1999 | Boston, MA |
| Endotoxin induction of luciferase activity in mice transgenic for a COX-2 promoter-luciferase reporter construct. Freeman A, Herschman H, Voznesensky O, Bhatt A, Clark S, Pilbeam C. | Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases | 1999 | Boston, MA |
| Effects of prostaglandin G/H synthase-2 knockout on bone. Okada won Young Investigator Award for his presentation. Okada Y, Tomita M, Tsurukami H, Nakamura T, Alander C, Sohn J, Raisz L, Lorenzo J, Pilbeam C. | Annual Meeting of the American Society for Bone and Mineral Research | 1999 | St. Louis, MO |
| The role of IL-1 in the bone loss of estrogen withdrawal. | Gerontological Society of America workshop | 1998 | Philadelphia, PA. |
| COX-2 and bone resorption. | Clinical Roundtable: Preferential Cyclooxygenase Inhibitors-Their Impact in the Prevention and Manag | 1998 | Frankfurt, Germany. |
| Role of COX-2 in the inflammatory process of bone resorption. Clinical Benefits of Selective COX-2 Inhibitors | William Harvey Research Conference | 1998 | Boston,MA |
| Role of COX-2 in bone formation and resorption. | Workshop: Is COX-2 a Physiologic Necessity? | 1998 | NYC |
| COX-2 and bone resorption. The Promise of Specific Cox-2 Inhibition by Novel Agents | William Harvey Research Conference | 1998 | Cannes, France |
| Regulation of inducible prostaglandin G/H synthase in bone. | International Conference on Biological Mechanisms of Tooth Eruption, Resorption, and Replacement by | 1997 | Toledo, Spain |
| Expression and regulation of Cox-2 in bone. | First International Workshop on Cox-2 | 1997 | New Orleans |
| Retinoic acid transcriptionally inhibits prostaglandin G/H synthase expression in osteoblastic cells. Pilbeam C, Herschman H, Alander C, Voznesensky O, Raisz L. | Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases | 1997 | La Jolla, CA |
| Decreased parathyroid-stimulated resorption in cultured calvaria from neonatal mice with resistance to collagenase. Pilbeam C, Zhao W, Krane SM. | Gordon Research Conference, Matrix Metalloproteinases | 1997 | Andover, NH |
| Regulation of prostaglandin synthesis in bone. | 10th International Conference on Prostaglandins and Related Compounds | 1996 | Vienna, Austria |
| Osteoblastic differentiation reduces serum induced transcription of prostaglandin G/H synthase-2 in MC3T3-E1 cells. Pilbeam CC, Voznesensky OS, Alander CB, Raisz LG. | Bone, Abstracts from the Sixth Workshop on Cells and Cytokines in Bone and Cartilage | 1996 | |
| The role of prostaglandins as local regulators of bone metabolism. | Research Trends in Osteoporosis, IBC UK Conference | 1995 | London, England |
| Regulation of inducible prostaglandin G/H synthase promoter activity by transforming growth factor ß in osteoblastic MC3T3 E1 cells. Pilbeam C, Kawaguchi H, Voznesensky O, Alander C, Fletcher B, Herschman H, Raisz LG. | Xllth International Conference on Calcium Regulating Hormones | 1995 | Melbourne, Australia |
| The regulation of prostaglandin synthesis in bone tissue. | Workshop on Prostaglandin and Bone: From Basic Research to Clinical Medicine | 1994 | Brussels, Belgium |
| Regulation of inducible prostaglandin G/H synthase by interleukin 1, transforming growth factors alpha and ß, and prostaglandins in bone cells. Pilbeam CC, Kawaguchi H, Voznesensky O, Alander CB, Raisz LG. | 3rd International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and | 1993 | Washington DC |
| Separate regulation of the mRNA transcripts for the two prostaglandin endoperoxide synthases In MC3T3 E1 osteoblastic cells by serum and glucocorticoid. Pilbeam CC, Kawaguchi H, Voznesensky O, Alander CB, Raisz LG. | XXIIIrd European Symposium on Calcified Tissues | 1993 | Heidelberg, Germany |
| Effects of calcium supple mentation on bone turnover in healthy older women Pannullo AM, Prestwood KM, Pilbeam CC, Raisz LG. | Annual meeting of the Gerontological Society of America | 1993 | |
| aging bone | Yale New Haven Hospital Grand Rounds | 1993 | Yale New Haven Hospital |
| Anabolic effect of progesterone on cultured fetal rat calvarial bone. Manzi DL, Pilbeam CC, Raisz LG. | Society for Gynecologic Investigations | 1993 | |
| The effects of tamoxifen on bone turnover, lipids, and health perception in older women. Kenny AM, Prestwood KM, Pilbeam CC, Raisz L. | American Geriatrics Society | 1993 | |
| osteoporosis and aging | Hartford Hospital Grand Rounds | 1992 | Hartford Hospital |
| Quantitative reverse transcrip¬tase PCR: A new method to assess the expression of prostaglandin endoperoxide synthase in bone. Yavari R, Stover ML, Pilbeam C, Kawaguchi H, Raisz LG, Rowe D. | East Coast Connective Tissue Conference | 1992 | |
| osteomalacia | John Dempsey Hospital Grand Rounds | 1991 | John Dempsey Hospital |
| Inhibition of prostaglandin E2 production by 17ß estradiol in osteoblast like cells. Pilbeam C, Gustafson S, Alander C, Raisz LG. | The American Geriatrics Society meeting | 1991 | Chicago, IL |
| In vitro inhibition of interleukin 1 stimulated prostaglandin E2 production by 17ß-estradiol. PiIbeam CC, Alander CB, Raisz LG. | Third International Workshop on Cells and Cytokines in Bone and Cartilage | 1990 | Davos, Switzerland |
| osteoporosis | Winsted Memorial Hospital Grand Rounds | 1990 | Winsted Memorial Hospital |
| vitamin D and aging | Mt. Sinai Hospital Grand Rounds | 1990 | Mt. Sinai Hospital |
| osteoporosis | St. Francis Hospital Grand Rounds | 1990 | St. Francis Hospital |
| Interaction of estrogen and PTH in osteoporosis. | NIH-sponsored Brookdale Foundation Summer Institute on Aging Research | 1989 | Bethesda, MD |
| osteoporosis | William Beaumont Hospital Grand Rounds | 1989 | Detroit, MI |
| In vitro inhibition of PTH stimulated resorption and prostaglandin production by 17ß estradiol. | Steenbock Symposium on Osteoporosis | 1989 | Madison, WI |
| In vitro inhibition of PTH stimulated prostaglandin E2 production by 17ß estradiol. Pilbeam CC, Raisz LG. | Annual Meeting of the American Society for Bone and Mineral Research | 1988 | New Orleans, LA |
| Vitamin D status in nursing home elders. Pilbeam CC, Webb AR, Holick MF. | Annual Meeting of the Gerontological Society of America | 1988 | San Francisco, CA |
| (geriatrics, osteoporosis) | Waterbury Hospital Grand Rounds | 1988 | Waterbury Hospital |
| Pilbeam CC, Webb AR, Hanifin N, Holick MF. Vitamin D status of residents in Boston nursing home. | The American Geriatrics Society meeting | 1988 | Boston, MA |
| (osteoporosis) | St. Vincent's Medical Center Grand Rounds | 1987 | St. Vincent's Medical Center, Bridgeport |